111 Inc (YI)
0.62
+0.01
(+1.14%)
USD |
NASDAQ |
Nov 22, 14:08
111 Total Liabilities (Quarterly): 349.81M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 349.81M |
| March 31, 2024 | 371.71M |
| December 31, 2023 | 396.83M |
| September 30, 2023 | 417.44M |
| June 30, 2023 | 332.16M |
| March 31, 2023 | 375.96M |
| December 31, 2022 | 409.55M |
| September 30, 2022 | 333.01M |
| June 30, 2022 | 354.74M |
| March 31, 2022 | 351.49M |
| December 31, 2021 | 360.39M |
| September 30, 2021 | 339.95M |
| June 30, 2021 | 347.07M |
| Date | Value |
|---|---|
| March 31, 2021 | 285.26M |
| December 31, 2020 | 259.57M |
| September 30, 2020 | 267.40M |
| June 30, 2020 | 182.54M |
| March 31, 2020 | 137.70M |
| December 31, 2019 | 119.54M |
| September 30, 2019 | 102.65M |
| June 30, 2019 | 102.06M |
| March 31, 2019 | 75.69M |
| December 31, 2018 | 46.90M |
| September 30, 2018 | 52.27M |
| June 30, 2018 | 51.53M |
| December 31, 2017 | 68.09M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
119.54M
Minimum
Dec 2019
417.44M
Maximum
Sep 2023
315.37M
Average
347.07M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Dr Reddy's Laboratories Ltd | 1.871B |
| Zai Lab Ltd | 317.68M |
| Concord Medical Services Holdings Ltd | 646.89M |
| Sinovac Biotech Ltd | 1.390B |
| CASI Pharmaceuticals Inc | 49.77M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 383.75M |
| Shareholders Equity (Quarterly) | -84.76M |
| Debt to Equity Ratio | -0.3074 |
| Current Ratio | 1.072 |
| Net Debt Paydown Yield | 2.88% |